Dr. Hodgson is an associate professor and clinician scientist in the Department of Radiation Oncology, and the Institute of Health Policy, Management and Evaluation, University of Toronto. He is the vice-chair of the Children's Oncology Group Hodgkin Lymphoma Committee, and a member of the COG Cardiac Late Effects Task Force, and the Haematology Disease Site Group of Cancer Care Ontario. His research activities include the utilization of population-based health administrative data to evaluate the treatment and outcome of cancer patients, particularly late effects. Recent work has included population-based evaluations of “new agents” funded through CCO's New Drug Funding Program, as well as new radiation therapy technologies including sterotactic radiosurgery (SRS) and intensity modulated radiation therapy (IMRT).<\/p>\n","protected":false},"excerpt":{"rendered":"
Dr. Hodgson is an associate professor and clinician scientist in the Department of Radiation Oncology, and the Institute of Health Policy, Management and Evaluation, University of Toronto. He is the vice-chair of the Children's Oncology Group Hodgkin Lymphoma Committee, and a member of the COG Cardiac Late Effects Task Force, and the Haematology Disease Site […]<\/p>\n","protected":false},"featured_media":16991,"template":"","migration-helper-automated":[],"migration-manual":[],"ices_title":[74],"migration-helper-qa-sample-set":[],"class_list":["post-1261","ices_scientist","type-ices_scientist","status-publish","has-post-thumbnail","hentry","ices_title-affiliate-scientist"],"acf":{"first_name":"David","last_name":"Hodgson","secondary_title":"","education":[{"title":"FRCPC, Radiation Oncology"},{"title":"MPH, Harvard University"},{"title":"MD, University of Toronto"},{"title":"BSc, Genetics, University of Western Ontario"}],"other_affiliations":[{"title":"Associate Professor and Clinician Scientist, Department of Radiation Oncology, and the\u00a0Institute of Health Policy, Management and Evaluation, University of Toronto"},{"title":"Staff Radiation Oncologist, Princess Margaret Hospital"}],"journal_article":[2213,3351,2949,6185,13182,5325,6256,2639,6418,5288,5133,4262,1707,1464,5184,6274,3353,3374,6147,3572,1480,22281,23213],"research_report":"","atlas":"","site":[6733],"research_program":[6741],"research_focus":[10768,10786,10738],"grant":"","award_or_recognition":"","news_release":"","ahrq_project":"","private_project":"","public_project":"","video":"","contact_display":"form","email":"david.hodgson@rmp.uhn.on.ca","display_email":false,"twitter_handle":"","display_twitter":false,"phone":"416-480-6047","phone_extension":"89332","display_phone":false,"assistant_name":"","assistant_title":"","display_assistant_name":false,"assistant_phone":"","assistant_phone_extension":"","display_assistant_phone":false,"sitecore_item_id":"0FDA1DFE-97C3-41FE-AD90-6966265DC178","sitecore_item_name":"David-Hodgson","sitecore_field_values":"{\n \"First Name\": \"David\",\n \"Last Name\": \"Hodgson\",\n \"Profile Image\": \"
Dr. Hodgson is an associate professor and clinician scientist in the Department of Radiation Oncology, and the Institute of Health Policy, Management and Evaluation, University of Toronto. He is the vice-chair of the Children's Oncology Group Hodgkin Lymphoma Committee, and a member of the COG Cardiac Late Effects Task Force, and the Haematology Disease Site Group of Cancer Care Ontario. His research activities include the utilization of population-based health administrative data to evaluate the treatment and outcome of cancer patients, particularly late effects. Recent work has included population-based evaluations of “new agents” funded through CCO's New Drug Funding Program, as well as new radiation therapy technologies including sterotactic radiosurgery (SRS) and intensity modulated radiation therapy (IMRT).<\/p>\",\n \"Close spellings\": \"Hodgeson\",\n \"Join Date\": \"19991004T122600\"\n}","previous_url":"https:\/\/www.ices.on.ca\/About-ICES\/ICES-Scientists\/H\/David-Hodgson"},"yoast_head":"\n